As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Ozempic, Wegovy and Mounjaro are often the most popular weight loss drugs. While these medications help people lose weight, they have undesirable side effects. Now, scientists at the University of ...

Gender bias in cardiac treatment guidelines is putting women at risk because guidelines are written based on clinical trials conducted mostly in men. As previously reported in BioWorld, nearly 70% of ...

The Ipsos survey of 1,078 adults found 24% of people would use weight-loss jabs if they were provided for free by the health ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...

As Africa continues to battle an outbreak of the newer "clade Ib" strain of mpox, California officials have confirmed the ...

A total of nearly 137 million adults, representing more than half of all U.S. adults, are eligible for semaglutide therapy. This ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...